Inventor · disambiguated record
Patrick James Knerr
Also filed as: KNERR PATRICK J · KNERR PATRICK JAMES
4 granted patents·7 pending applications·6 citations·filing 2019–2023
66Inventor score
Files withNOVO NORDISK AS11
Top patents by PatentIndex Score
11 records- 0184US10604555B2GIP derivatives and uses thereofNOVO NORDISK AS·Filed 2019·Granted Mar 31, 2020·5 cites·30 claims
- 0280US11633459B2GIP derivatives and uses thereofNOVO NORDISK AS·Filed 2019·Granted Apr 25, 2023·1 cites·19 claims
- 0377US11779648B2Co-agonists at GLP-1 and GIP receptors suitable for oral deliveryNOVO NORDISK AS·Filed 2022·Granted Oct 10, 2023·0 cites·1 claims
- 0476US2023120597A1Co-agonists at glp-1 and gip receptors suitable for oral deliveryNOVO NORDISK AS·Filed 2022·Application pending·0 cites
- 0574US11840560B2Prodrugs and uses thereofNOVO NORDISK AS·Filed 2023·Granted Dec 12, 2023·0 cites·1 claims
- 0673US2024190938A1Gip derivatives and uses thereofNOVO NORDISK AS·Filed 2023·Application pending·0 cites
- 0771US2023272029A1Co-agonists at glp-1 and gip receptors suitable for oral deliveryNOVO NORDISK AS·Filed 2021·Application pending·0 cites
- 0871US2022177538A1Co-agonists at glp-1 and gip receptors suitable for oral deliveryNOVO NORDISK AS·Filed 2021·Application pending·0 cites
- 0970US2024083965A1Prodrugs and uses thereofNOVO NORDISK AS·Filed 2023·Application pending·0 cites
- 1054US2023346961A1Glp-1 and gip receptor co-agonistsNOVO NORDISK AS·Filed 2021·Application pending·0 cites
- 1150US2023391845A1Glp-1, gip and glucagon receptor triple agonistsNOVO NORDISK AS·Filed 2021·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Patrick James Knerr files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →